$414 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 21 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EYES | Exit | SECOND SIGHT MED PRODS INC | $0 | – | -50,804 | -100.0% | -0.02% | – |
AXK | Exit | ACCELERATE DIAGNOSTICS INCcall | $0 | – | -516,400 | -100.0% | -0.22% | – |
BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -776,900 | -100.0% | -0.29% | – |
AGEN | Exit | AGENUS INC | $0 | – | -1,547,392 | -100.0% | -1.77% | – |
BIOL | Exit | BIOLASE INC | $0 | – | -30,866,262 | -100.0% | -3.04% | – |
MZOR | Exit | MAZOR ROBOTICS LTDsponsored ads | $0 | – | -246,317 | -100.0% | -3.66% | – |
AXK | Exit | ACCELERATE DIAGNOSTICS INC | $0 | – | -4,447,618 | -100.0% | -24.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
BIOGEN INC | 42 | Q3 2023 | 0.6% |
QUIDEL CORP | 36 | Q1 2022 | 52.5% |
AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
VERMILLION INC | 28 | Q1 2020 | 3.8% |
AGENUS INC | 25 | Q3 2023 | 9.8% |
TESARO INC | 23 | Q4 2018 | 27.8% |
ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.